Binex cuts biopharmaceutical manufacturing supply contract value to 15.92 billion won
Binex corrected its sales and supply contract, cutting value to 15.92 billion won from 17.44 billion and revising revenue impact to 10.28% from 11.27%. Contract end date extended to Dec. 31, 2027 from Sept. 30, 2026 and the disclosure hold deadline moved to Dec. 31, 2027.